Use of biomarkers in clinical trials.

被引:0
|
作者
Ransohoff, DF [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2768S / 2768S
页数:1
相关论文
共 50 条
  • [31] Quality of life assessment in clinical trials.
    Cramer, JA
    [J]. EPILEPSIA, 1999, 40 : 214 - 214
  • [32] Experimental analytical trials. The clinical trial
    Conejero, Antonio Martin
    Garcia, Marcos Alonso
    [J]. ANGIOLOGIA, 2024, 76 (01): : 30 - 37
  • [33] Diversity in multiple myeloma clinical trials.
    Duma, Narjust
    Velez, Miguel Gonzalez
    Vera-Aguilera, Jesus
    Parrondo, Richardo
    Mariotti, Veronica
    Paludo, Jonas
    Wang, Yucai
    Go, Ronald
    Adjei, Alex
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 68 - 68
  • [34] Use of biomarkers in ALS drug development and clinical trials
    Bakkar, Nadine
    Boehringer, Ashley
    Bowser, Robert
    [J]. BRAIN RESEARCH, 2015, 1607 : 94 - 107
  • [35] Considerations About the Use of Biomarkers in Cancer Clinical Trials
    Chabner, Bruce A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 25 - 27
  • [36] Update on the use of biological markers to monitor outcome in alcoholism clinical treatment trials.
    Anton, RF
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 56A - 56A
  • [37] The use of complementary and alternative medicine (CAM) in cancer patients participating in clinical trials.
    Epelbaum, R
    Vizel, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 543S - 543S
  • [38] Academic and community physician perspectives on breast cancer biomarker use in clinical trials.
    Thannickal, Halle H.
    Eltoum, Noon
    Andrews, Courtney J.
    Frazier, Rachel Marie
    Wagner, Lynne I.
    Wallner, Lauren P.
    Wolff, Antonio C.
    Rocque, Gabrielle Betty
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 349 - 349
  • [39] Good clinical practices in monitoring antihypertensive clinical trials.
    Jett, CM
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 115A - 115A
  • [40] Measurement of somatic neuropathy for clinical practice and clinical trials.
    Scott L.V.
    Tesfaye S.
    [J]. Current Diabetes Reports, 2001, 1 (3) : 208 - 215